# Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome

> **NCT00603109** · PHASE3 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 10 (actual)

## Conditions studied

- Prader-willi Syndrome

## Interventions

- **DRUG:** rimonabant
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00603109
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-08
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Drug side effects leading to premature stop
- **Last updated:** 2023-03-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00603109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00603109, "Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00603109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*